Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission.

Mehta N, Maragulia JC, Moskowitz A, Hamlin PA, Lunning MA, Moskowitz CH, Zelenetz A, Matasar MJ, Sauter C, Goldberg J, Horwitz SM.

Clin Lymphoma Myeloma Leuk. 2013 Dec;13(6):664-70. doi: 10.1016/j.clml.2013.07.005. Epub 2013 Sep 11.

PMID:
24035712
[PubMed - indexed for MEDLINE]
2.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
[PubMed - indexed for MEDLINE]
3.

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.

Kim MK, Kim S, Lee SS, Sym SJ, Lee DH, Jang S, Park CJ, Chi HS, Huh J, Suh C.

Ann Hematol. 2007 Jun;86(6):435-42. Epub 2007 Jan 26.

PMID:
17256144
[PubMed - indexed for MEDLINE]
4.

Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.

Prochazka V, Faber E, Raida L, Vondrakova J, Kucerova L, Jarosova M, Indrak K, Papajik T.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):63-6.

PMID:
19365529
[PubMed - indexed for MEDLINE]
Free Article
5.

High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.

Rodriguez J, Caballero MD, Gutierrez A, Gandarillas M, Sierra J, Lopez-Guillermo A, Sureda A, Zuazu J, Marin J, Arranz R, Carreras E, Leon A, De Sevilla AF, San Miguel JF, Conde E; GEL/TAMO Spanish Group.

Haematologica. 2003 Dec;88(12):1372-7.

PMID:
14687990
[PubMed - indexed for MEDLINE]
Free Article
6.

Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcome.

Yang DH, Kim WS, Kim SJ, Bae SH, Kim SH, Kim IH, Yoon SS, Mun YC, Shin HJ, Chae YS, Kwak JY, Kim H, Kim MK, Kim JS, Won JH, Lee JJ, Suh CW.

Biol Blood Marrow Transplant. 2009 Jan;15(1):118-25. doi: 10.1016/j.bbmt.2008.11.010.

PMID:
19135950
[PubMed - indexed for MEDLINE]
7.

Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.

Gkotzamanidou M, Papadimitriou CA.

Crit Rev Oncol Hematol. 2014 Feb;89(2):248-61. doi: 10.1016/j.critrevonc.2013.08.016. Epub 2013 Sep 8.

PMID:
24075060
[PubMed - in process]
8.

Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.

Chen AI, McMillan A, Negrin RS, Horning SJ, Laport GG.

Biol Blood Marrow Transplant. 2008 Jul;14(7):741-7. doi: 10.1016/j.bbmt.2008.04.004.

PMID:
18541192
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis.

Gui L, Shi YK, He XH, Lei YH, Zhang HZ, Han XH, Zhou SY, Liu P, Yang JL, Dong M, Zhang CG, Yang S, Qin Y.

Int J Hematol. 2014 Jan;99(1):69-78. doi: 10.1007/s12185-013-1465-y. Epub 2013 Nov 21.

PMID:
24258711
[PubMed - indexed for MEDLINE]
10.

18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma.

Casulo C, Schöder H, Feeney J, Lim R, Maragulia J, Zelenetz AD, Horwitz S.

Leuk Lymphoma. 2013 Oct;54(10):2163-7. doi: 10.3109/10428194.2013.767901. Epub 2013 Mar 4.

PMID:
23369041
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.

Rodríguez J, Caballero MD, Gutiérrez A, Marín J, Lahuerta JJ, Sureda A, Carreras E, León A, Arranz R, Fernández de Sevilla A, Zuazu J, García-Laraña J, Rifon J, Varela R, Gandarillas M, SanMiguel J, Conde E.

Ann Oncol. 2003 Dec;14(12):1768-75.

PMID:
14630683
[PubMed - indexed for MEDLINE]
Free Article
12.

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.

Blystad AK, Enblad G, Kvaløy S, Berglund A, Delabie J, Holte H, Carlson K, Kvalheim G, Bengtsson M, Hagberg H.

Bone Marrow Transplant. 2001 Apr;27(7):711-6.

PMID:
11360110
[PubMed - indexed for MEDLINE]
Free Article
13.

The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience.

Rodríguez J, Conde E, Gutiérrez A, Arranz R, León A, Marín J, Bendandi M, Albo C, Caballero MD.

Ann Oncol. 2007 Apr;18(4):652-7. Epub 2007 Jan 17.

PMID:
17229774
[PubMed - indexed for MEDLINE]
Free Article
14.

Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas.

Iriyama N, Takahashi H, Hatta Y, Miura K, Kobayashi Y, Kurita D, Hirabayashi Y, Hojo A, Kodaira H, Yagi M, Kiso S, Uchino Y, Nakagawa M, Kusuda M, Kobayashi S, Horikoshi A, Kura Y, Yamazaki T, Sawada U, Takeuchi J.

Oncol Rep. 2013 Feb;29(2):805-11. doi: 10.3892/or.2012.2143. Epub 2012 Nov 15.

PMID:
23166041
[PubMed - indexed for MEDLINE]
15.

High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.

Nademanee A, Palmer JM, Popplewell L, Tsai NC, Delioukina M, Gaal K, Cai JL, Kogut N, Forman SJ.

Biol Blood Marrow Transplant. 2011 Oct;17(10):1481-9. doi: 10.1016/j.bbmt.2011.02.008. Epub 2011 Feb 19.

PMID:
21338704
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.

Mikesch JH, Kuhlmann M, Demant A, Krug U, Thoennissen GB, Schmidt E, Kessler T, Schliemann C, Pohlen M, Mohr M, Evers G, Köhler G, Wessling J, Mesters R, Müller-Tidow C, Berdel WE, Thoennissen NH.

Ann Hematol. 2013 Aug;92(8):1041-8. doi: 10.1007/s00277-013-1738-9. Epub 2013 Mar 27.

PMID:
23532626
[PubMed - indexed for MEDLINE]
17.

Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.

Ahn JS, Yang DH, Jung SH, Chae YS, Sohn SK, Yhim HY, Kwak JY, Lee SR, Kim YK, Kim HJ, Lee JJ.

Ann Hematol. 2013 Jun;92(6):789-97. doi: 10.1007/s00277-013-1685-5. Epub 2013 Jan 29.

PMID:
23358616
[PubMed - indexed for MEDLINE]
18.

Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.

Yin J, Wei J, Xu JH, Xiao Y, Zhang YC.

Acta Haematol. 2014;131(2):114-25. doi: 10.1159/000353778. Epub 2013 Oct 19. Review.

PMID:
24158006
[PubMed - indexed for MEDLINE]
Free Article
19.

Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.

d'Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, Holte H, Österborg A, Merup M, Brown P, Kuittinen O, Erlanson M, Østenstad B, Fagerli UM, Gadeberg OV, Sundström C, Delabie J, Ralfkiaer E, Vornanen M, Toldbod HE.

J Clin Oncol. 2012 Sep 1;30(25):3093-9. doi: 10.1200/JCO.2011.40.2719. Epub 2012 Jul 30.

PMID:
22851556
[PubMed - indexed for MEDLINE]
Free Article
20.

Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.

Derenzini E, Musuraca G, Fanti S, Stefoni V, Tani M, Alinari L, Venturini F, Gandolfi L, Baccarani M, Zinzani PL.

Cancer. 2008 Nov 1;113(9):2496-503. doi: 10.1002/cncr.23861.

PMID:
18833583
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk